DOCSLIB.ORG

Brand Overview

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

CHANNEL MARKETING Meetings Focus provides the most varied, success-proven array of products in the marketplace. As you review your marketing goals and needs for the coming year, look to each of the opportunities within Meetings Focus, and we can deliver the right solution-based package for you! Web Units Programs Online Digital & Listings Video & Display Mobile WEB Edition Rich Media Packages Remarketing PRINT National Demographic International Guide Trends Supplements Meetings National Demographic Custom E-List in a EMAIL Newsletters Newsletters Newsletters Rental Minute On Location Meetings Educational Custom Custom Video LIVE Focus Live! Webinars Webinars FAM Broadcasts Lead Custom MARKETING Research SERVICES Generation Content NOVEMBER 2014 | MEETINGSFOCUS.COM The ALS Ice Bucket others, a great way to raise support.” videos, share an experience with others, and Challenge–a Brilliant Entry into the movement didn’t even have to feel like they were participating in a good, to cost money. Those who didn’t donate did charitable cause that was authentic. Many advocacy campaign! their bit to move a message and motivate would not have taken the dive into cold THE DESTINATION EXPERTS others. The playing field was level and many water had it not been for the charity piece. By Roger Rickard got onto it. “Emotion moves people to do and think CVB UPDATE things,” Rickard says. “I tell people to watch Editor’s note: The following excerpt was Harness Video Power. Videos are most the 70th anniversary video for the Ad sourced from a recent e-newsletter from likely to go viral these days on platforms Council on YouTube, and I ask them what Voices in Advocacy, a meetings industry A Special Advertising Section like Facebook and YouTube, as those about they see—emotion, children, pets, military, advocacy effort headed by Roger Rickard. the ALS challenge did. They offer more of a celebrities and messages that contain easily personal experience than a single image, say digested facts. That’s how you put a face on s of Tuesday, Aug. 26, 2014, the social media marketers. And most everyone your cause.” ALS Association had reported can record videos with their mobile devices, Areceiving $88.5 million in dona- so it’s easy to hit record and then upload to Avoid Controversy. People of all tions compared to $2.6 million during the social media. persuasions, political and otherwise—espe- same time period last year (July 29 to Aug. If you design a message you want to catch cially celebrities—could step into the ALS 26). WOW—over a 3,400 percent increase. MAKING fire online, Harris advises the use of images, challenge territory without fear of raising The donations have come from existing donors and 1.9 video and copy that are relevant and easy a ruckus, offending anyone or creating a million new donors. for users to duplicate. public relations problem for themselves. It ALS, also known as Lou Gehrig’s disease, is a neuro- degenerative condition that breaks down muscle control, The Palm “Give your audience [content] that is easy had universal appeal. for users to copy and paste. If you do, you’ll “Using celebrities can be very tricky, leading eventually to loss of life. According to the ALS Using viral marketing efforts to create a big impression find this will increase the number of people because somebody might attack them Association there are roughly 5,600 new people in the USA who will engage with and post about an for endorsing something even if it is well diagnosed annually. SPLASH! event,” she says. intentioned,” Rickard says. “The ALS The Ice Bucket Challenge has become hard to avoid—it Beaches A For Twitter, “pick a short, generic and challenge used big names in the way the is everywhere. It went viral on social media and became evergreen hashtag,” advises Guy Kawasaki, Jerry Lewis telethon used them for decades a pop culture phenomenon, particularly in the United ome social media and technology marketers say it was an online marketing guru and chief evan- to raise funds for muscular dystrophy. States, with numerous celebrities, politicians, athletes, Using viral marketing efforts to create a big impression Description sizes. Plus, there’s the state-of-the-art Palm Airport and Transportation gelist at Canva. “The big picture is that you Nobody attacks someone for wanting to and everyday Americans posting videos of themselves serendipity and good luck that it caught Internet fire and The Palm Beaches are the best way to meet in Beach County Convention Center featuring The Palm Beach International Airport was want a hashtag that’s constantly in people’s help kids with MD. So your issue or cause online and on TV participating in the event. It has very well Florida. This Sunshine State favorite boasts 47 over 100,000 square feet of exhibit hall space, voted by Condé Nast Traveler as the “3rd went beyond mere success to become a cultural “phenom.” faces, trending and consistent, whether it dictates whether and what celebrity should become one of the most successful advocacy awareness miles of sandy Atlantic coastline, more than including a 22,000-square-foot Grand Ball- Best Airport in the United States and 6th refers to an event or new television com- be attached to it.” campaigns in recent times. S 160 public and private golf courses, world-class room and 21,000 square feet of additional Best in the World.” It offers outstanding lift The it—that online summer “ice bucket chal- you create community, they will have a reason to mercials.” The ALS Ice Bucket Challenge is an advocacy campaign shopping that rivals any cosmopolitan center, flexible meeting space. from major markets and allows groups to ar- lenge” that brought in over $100 million for the attend your event. Organizers need to give people Don’t Forget the Influencers. Influ- pure and simple. They have reached, and I’m sure far BY RUTH A. HILL ALS Association from over 3 million donors—did something to talk about and social media can be Make It Self-Focused. The “selfie” encers from many walks of life, not just exceeded, their advocacy goals with this campaign. Let us and more than 200 hotels and resorts, many Moreover, the convention center is located rive mere minutes from beachfront resorts, more than raise a bundle of money for the orga- the platform.” culture can help you spread your message pop celebrities, got into the ALS challenge, take deeper look. with oceanfront locations and outstanding in the heart of the downtown arts and enter- downtown hotels and the convention center. nization, which funds research to support finding far and wide. People like to star in messag- Grossman points out, and this was a huge According to The New York Times people shared more golf and spa facilities, that are ideal for hosting tainment district, and just three miles away Additionally, travel in style with A1A Airport treatments and a cure for the disease. It also raised Keep It Simple. The ALS challenge was simple es they post to social media. So design a impetus. than 1.2 million videos on Facebook between June 1 and groups of all sizes and meeting agendas. from the airport and minutes from the beach- and Limousine Service, featuring executive public awareness and created a sympathetic world- (donate money, pour ice water over your head, or campaign that gives your audience direction Influencers who would have normally Aug. 13 and mentioned the phenomenon more than 2.2 The Palm Beaches became America’s es. Best of all, construction is underway on a town cars, stretch limousines, vans and bus- wide community to combat ALS, while entertain- both, and then challenge three friends to do the for creating content that’s more interesting cost huge fees for their endorsements or million times on Twitter between July 29 and Aug. 17. First Resort Destination® over a century ago. 403-room Hilton West Palm Beach, opening es to ensure a luxurious and safe experience. ing nearly everyone who stepped into its sphere. same), advocated a great cause, and it was fun. than a picture of the fish they ate for dinner. participation were creating and sharing Prior to the challenge, public awareness of the disease Today, while equipped with every modern in July 2016. It could not be more convenient But can an online messaging grassfire be du- Anyone could and did participate. The ALS challenge had people putting their videos. amyotrophic lateral sclerosis (ALS) was relatively limited; the convenience and incredible diversions, the from both a business and pleasure standpoint Climate plicated—and controlled—for use inside or about “If you are asking people to do something, themselves at the center of the action and “Just make sure you have influencers who ALS Association states that prior to the challenge going viral area still welcomes guests with a genuine to arrange a meeting in The Palm Beaches. The average annual temperature in The Palm meetings and events? Though nearly every social don’t make it complicated,” advises Emily Harris, bringing in others to help them dump the buy into your idea,” he advises. “This is key only half of Americans had heard of the disease, often re- sense of hospitality that’s truly one of its Beaches hovers around a perfect 78º, with media marketer agrees it’s nigh on impossible to digital marketing manager at Rockhouse Partners. water. And in this way, it became a commu- to good social by design. It enlarges your ferred to as “Lou Gehrig’s disease,” after the famous baseball greatest charms. Dining and F&B more sunny days than you can imagine and ensure a message goes viral, there are definitely “Think in terms of an ‘elevator pitch’ style, other- nity event.
Recommended publications
  • 46 L Nursing2015 L Volume 45, Number 10 46 L

    46 L Nursing2015 L Volume 45, Number 10 46 L

    46 l Nursing2015 l Volume 45, Number 10 www.Nursing2015.com Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. 2.0 ANCC ALCONTACT HOURSS Amyotrophic lateral sclerosis: What nurses need to know By Tamara L. Bellomo, MSN, RN-BC, and Lucille Cichminski, MSN, RN A MOTHER OF THREE teenage children, Mrs. is one of the most common neuromuscular dis- S, 49, presented to her healthcare provider eases in the world. This rapidly progressive, fatal with bilateral leg twitching and weakness, dif- neuromuscular disease involves the degeneration ficulty swallowing, and fatigue that’s worsened and death of the upper and lower motor neu- over the past few weeks. While she was on her rons.1 This article discusses the diagnosis and daily morning walk, she tripped and fell. She treatment of ALS and how nurses can help their experienced a small laceration to her leg, patients deal with the difficult diagnosis and find prompting her visit to the healthcare facility. the resources they and their families need. Her husband said that she’d had periods of slurred speech over the past few months as Who’s affected? well. She was alert and oriented, and her vital An estimated 20,000 to 30,000 Americans are signs were all within normal limits. living with ALS, and about 5,000 new cases After an exam, her healthcare provider are diagnosed each year in the United States.2 referred her to a neurologist who ordered This disease affects people of all ethnic, socio- magnetic resonance imaging (MRI), an electro- economic, and racial backgrounds.2,3 ALS most HOTOTAKE / P myogram, and a full bloodwork panel.
  • Drug Development for Amyotrophic Lateral Sclerosis Guidance for Industry

    Drug Development for Amyotrophic Lateral Sclerosis Guidance for Industry

    Drug Development for Amyotrophic Lateral Sclerosis Guidance for Industry August 2017 Contents I. INTRODUCTION ................................................................................................................ 1 II. BACKGROUND ................................................................................................................... 2 III. BENEFIT RISK...................................................................................................................... 5 A. General comments .................................................................................................................. 5 B. Evidence of patient and caregiver preferences ....................................................................... 5 C. Implications of patient risk/benefit preferences in ALS ......................................................... 7 1. Alternative endpoints........................................................................................................... 7 2. Placebo control arm ............................................................................................................. 8 3. Threshold for statistical significance ................................................................................... 9 4. Method of delivery ............................................................................................................ 10 5. Role of expanded access and accelerated approval ........................................................... 11 6. Patient protection and need for informed
  • 2020-ALS-Mission-Toolkit Web.Pdf

    2020-ALS-Mission-Toolkit Web.Pdf

    OUR MISSION OUR MISSION TABLE OF CONTENTS OUR MISSION Our Case for Support . iv Annual Impact . v Our Vision and Mission . vi CHAPTER 1: RESEARCH The ALS Association Research Program The ALS Association Research Program . 1–1 Research . 1–5 Our Strategic Initiatives . 1–5 Infographics Current Projects . 1–13 Accelerating the Search for a Cure . 1–14 Research By the Numbers . 1–15 Research Strategy . 1–16 Funded Research . 1–17 Scientific Focus Areas . 1–18 Advances in ALS Research . 1–20 Research Initiatives The ALS Association’s ALS Roundtable Program . 1–22 ALS Voice of The Patient Report . 1–24 ALS Focus Survey Program . 1–26 Research Staff . 1–28 CHAPTER 2: CARE SERVICES How We Work Summary . 2–1 How We Work . 2–2 Chapter Membership . 2–4 ii How We Support Clinical Care Supporting Clinical Care . 2–11 Certified Centers . 2–14 Where We Support Care . 2–15 Impact & Resources Care Services Impact . 2–20 Filling the Gap . 2–21 Education — Living with ALS: General Scope . 2–22 Education — Living with ALS: Medical Resources . 2–24 Assistive Technology — Assistive Technology in the ALS Space . 2–26 Children’s Programs and Resources . 2–28 The Jane Calmes ALS Scholarship Fund . 2–32 ALS Association Care Connection . 2–33 Care Services Staff . 2–34 CHAPTER 3: ADVOCACY Introduction To ALS Advocacy Introduction . 3–1 History of ALS Advocacy . 3–2 History of ALS Advocacy: Timeline . 3–3 Advocacy Action Advocacy Guiding Principles . 3–5 How We Advocate . 3–6 Priorities, Impact, and Coalitions ALS Guidance . 3–10 Advocacy Impact .
  • A Er the Wildly Successful Ice Bucket Challenge

    A Er the Wildly Successful Ice Bucket Challenge

    RESEARCH FEBRUARY/MARCH 2015 BY GINA SHAW Azer the Wildly Successful Ice Bucket Challenge ~e Ice Bucket Challenge raised big bucks on social media. Now, the ALS Association tells us where that cold, hard cash is going. As snowstorms and icy winds batter much of the country, it's hard to imagine willingly pouring a bucket of ice water over your head for any reason. But last August—when temperatures were much more forgiving—that's exactly what about 3 million people did. In an astonishing example of the power of social media, a July 31 dare from former Boston College baseball player Pete Frates, who was diagnosed with amyotrophic lateral sclerosis (ALS) in 2012, quickly went viral. The dare? Dump ice water on your head within 24 hours of being challenged or donate $100 (or whatever amount you could afford) to the ALS Association or another organization supporting ALS research. Pretty soon, the Ice Bucket Challenge meant dumping ice on your head and donating money, and everyone from your neighbor's preschooler to Bill Gates (with a custom-built ice douser), Oprah Winfrey, Jon Bon Jovi, and entire casts of Broadway shows were doing it—and posting their videos online. Even 86-year-old Ethel Kennedy took the challenge. (President Obama donated but declined the ice; actor Patrick Stewart posted a video of himself writing a check.) In La Jolla, CA, prominent ALS researcher Don Cleveland, PhD, who pioneered a novel therapy that turns off the defective genes that contribute to neurodegenerative diseases, watched the online commotion with skepticism.

  • Real Or Perceived Amyotrophic Lateral Sclerosis (ALS) Objectives

    10/11/2019 Nursing Care and Considerations of Patients with Amyotrophic Lateral Sclerosis (ALS) 40th Annual Neurorehabilitation Conference on Traumatic Brain Injury, Stroke and Other Neurological Disorders Saturday & Sunday, November 16 & 17, 2019 Hyatt Regency Cambridge 575 Memorial Drive • Cambridge, MA encompasshealth.com/braintreerehab Vincent M. Vacca, Jr., MSN, RN 1 Conflicts of interest – Real or Perceived • NONE 2 Amyotrophic Lateral Sclerosis (ALS) Objectives: 1. Following this presentation the learner will be able to list three signs and symptoms of motor neuron dysfunction found in ALS. 2. Following this presentation the learner will be able to explain three diagnostic tests utilized to establish diagnosis of ALS. 3. Following this presentation the learner will be able to describe three essential nursing interventions guided by best practices and care of patients with ALS. 3 1 10/11/2019 The median age of ALS onset is 55 years • ALS affects about one in every 300 people. • About 30,000 currently with 5,000 new cases per year. • ALS is sporadic in 90% of cases and show familial inheritance in the remaining 10%. • Estimates of the median survival of people with ALS vary between 27 and 64 months. • Death from ALS is primarily pulmonary. 4 ALS is the most frequent motor neuron disorder in adults • Due to degeneration of upper and lower motor neurons in spinal and bulbar myotomes. • Most studies show male predominance with a gender ratio of 3:2, but gender differences are age related. • Age of onset tends to be later in females than in males (68.4 years vs. 61.5 years).

  • Amyotrophic Lateral Sclerosis (ALS)?

    Amyotrophic Lateral Sclerosis U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Amyotrophic Lateral Sclerosis What is amyotrophic lateral sclerosis (ALS)? myotrophic lateral sclerosis (ALS) is a A rare neurological disease that affects nerve cells (neurons) in the brain and spinal cord that control voluntary muscle movement. Voluntary muscles produce movements like chewing, walking, breathing and talking. The disease is progressive, meaning the symptoms get worse over time. Currently, there is no cure for ALS and no effective treatment to halt, or reverse, the progression of the disease. ALS belongs to a wider group of disorders known as motor neuron diseases, which are caused by gradual deterioration (degeneration) and death of motor neurons. Motor neurons are nerve cells that extend from the brain to the spinal cord and to muscles throughout the body. These motor neurons initiate and provide vital communication links between the brain and the voluntary muscles. Messages from motor neurons in the brain (called upper motor neurons) are transmitted to motor neurons in the spinal cord and to motor nuclei of brain (called lower motor neurons) and from the spinal cord and motor nuclei of brain to a particular muscle or muscles. 1 In ALS, both the upper motor neurons and the lower motor neurons degenerate or die, and stop sending messages to the muscles. Unable to function, the muscles gradually weaken, start to twitch (called fasciculations), and waste away (atrophy). Eventually, the brain loses its ability to initiate and control voluntary movements. Early symptoms of ALS usually include muscle weakness or stiffness. Gradually all muscles under voluntary control are affected, and individuals lose their strength and the ability to speak, eat, move, and even breathe.
  • UAMS Scientists Create Promising Mouse Model for Reaching Cure for ALS

    UAMS Scientists Create Promising Mouse Model for Reaching Cure for ALS

    UAMS News Bureau Office of Communications & Marketing 4301 West Markham # 890 Little Rock, AR 72205-7199 uamshealth.com/news News Release Feb. 14, 2017 Media Contacts: Leslie W. Taylor, 501-686-8998 Wireless phone: 501-951-7260 [email protected] Liz Caldwell, 501-686-8995 Wireless phone: 501-350-4364 [email protected] UAMS Scientists Create Promising Mouse Model for Reaching Cure for ALS LITTLE ROCK — Researchers at the University of Arkansas for Medical Sciences (UAMS) have found a new way to replicate Lou Gehrig’s disease in mice, in what they hope will bring scientists one big step closer to a cure. Mahmoud Kiaei, Ph.D., an assistant professor in the department of Pharmacology and Toxicology in the UAMS College of Medicine, published the project recently in Human Molecular Genetics, a peer-reviewed journal published by The Oxford University Press on all topics related to human molecular genetics. https://www.ncbi.nlm.nih.gov/pubmed/28040732 Lou Gehrig’s disease, also called amyotrophic lateral sclerosis (ALS), attacks the nerve cells that control muscles, called motor neurons. Patients become progressively weaker, eventually losing the ability to speak, eat, move and breathe. There is no cure and the disease is 100 percent fatal. Death sometimes occurs as fast as six months to a year after diagnosis. “Advances like this give me lots of hope and optimism that we will be able to discover a drug to treat ALS sooner,” Kiaei said. About 10 percent of ALS cases in the United States are inherited. In the mid-‘90s, after the identification of one gene associated with ALS, scientists first replicated human ALS in mice, creating a so-called “mouse model.” For many years, it remained the only mouse model available for ALS testing, but it failed to yield a drug treatment that was replicable in human clinical trials.
  • ALS:The Basics

    ALS:The Basics

    ALS: The Basics WHAT IS ALS? Amyotrophic lateral sclerosis (ALS), sometimes called Lou Gehrig’s disease after the New York Yankees baseball player whose career ended in 1939 because of the illness, is a progressive neurodegenerative condition that affects the nerve cells (motor neurons) in the brain and spinal cord that control voluntary movement. ALS most commonly occurs in people between the ages of 40 and 70, but younger and older individuals also can develop the disease. WHAT ARE THE SYMPTOMS? Weakness and loss of muscle mass (atrophy), which occur as a result of the degeneration of motor neurons, are the primary symptoms. In later stages, people may be unable to stand or walk, use their hands and arms, chew and swallow food, or speak. They ultimately may be unable to breathe without the support of a machine (mechanical ventilation). The disease is almost always fatal, usually because the muscles necessary for breathing become too weak. On average, people survive for about three to five years, but up to 10 percent will live for 10 years or more. WHAT CAUSES IT? ALS is caused by degeneration of the motor neurons, but scientists have not yet discovered why the disease occurs in some people but not others. Ninety to 95 percent of ALS cases are sporadic, meaning they occur randomly, with no clear risk factors or causes. Individuals with sporadic ALS have no family history of the disease, nor are their family members at increased risk of developing it. In the hereditary form of ALS (only 5 to 10 percent of cases), researchers have identified mutations in more than a dozen genes.
  • ENCALS 2017: Book of Abstracts

    ENCALS 2017: Book of Abstracts

    Book of abstracts Organised by: European Network to Cure ALS Local Organisers: Ljubljana ALS Centre, Institute of Clinical Neurophysiology University Medical Centre Ljubljana, Slovenia Slovenian Society of Clinical Neurophysiology Editors: Ana Štublar Petra Prunk Blaž Koritnik Technical editor: Miha Cuznar Design: Brane Žalar Publisher: Slovenian Society of Clinical Neurophysiology Ljubljana, 2017 Kataložni zapis o publikaciji (CIP) pripravili v Narodni in univerzitetni knjižnici v Ljubljani COBISS.SI-ID=290258688 ISBN 978-961-94228-0-9 (pdf) - 2 - Contents Welcome Address .................................................................................................................................................... 4 Committees ............................................................................................................................................................... 5 Scientific Programme ............................................................................................................................................. 8 Poster Sessions ......................................................................................................................................................... 15 Registration and Fees ........................................................................................................................................ 33 General Information .........................................................................................................................................
  • 2021 ALS Association Mission Toolkit

    2021 ALS Association Mission Toolkit

    OUR Mission 2021 ALS Association Mission Toolkit 4/15/21 FOR INTERNAL USE ONLY “The ALS Association has been the greatest organizationALS PROOF to be affiliated with because they’ve got chapters around the country to help patients and their families. They do that through support groups and providing in-home care where people may not be able to afford the cost. And that gives a break to the loved ones, the family members that are left to take care of us when we can’t take care of ourselves. ” —John Russo Co-Chair, ALS Focus Patient and Caregiver Advisory Committee Our Mission TABLE OF CONTENTS Our Case for Support . vi Our Impact . vii Our Vision and Mission . viii Our Research The ALS Association Research Program The ALS Association Research Program . 1-1 Research . 1-4 Research Infographics Scientific Focus Areas . 1-12 Current Projects . 1-14 Accelerating the Search for A Cure . 1-15 Research By the Numbers . 1-16 Funded Research . 1-17 Advances in ALS Research . 1-18 Mission Initiatives The ALS Association’s ALS Roundtable Program . 1-20 Thank You to Our 2020 Roundtable Sponsors . 1-22 ALS Voice of The Patient Report . .4/15/21 . .FOR . .INTERNAL . .USE . ONLY 1-23 ALS Focus Survey Program . 1-25 Research Staff . 1-28 Our Care NetworkALS PROOF How We Work Summary . 2-1 How We Work . 2-2 Chapter Membership . 2-4 iv 2021 ALS Association Mission Toolkit How We Support Clinical Care Supporting Clinical Care . 2-11 Certified Centers . 2-14 Where We Support Care . 2-15 Impact & Resources Care Services Impact .
  • Amyotrophic Lateral Sclerosis (ALS)

    Amyotrophic Lateral Sclerosis (ALS)

    The following excerpt has been taken from the Christopher & Dana Reeve Foundation Paralysis Resource Center website. http://www.christopherreeve.org/site/c.mtKZKgMWKwG/b.4452343/k.2B93/Amyotroph ic_Lateral_Sclerosis.htm Amyotrophic Lateral Sclerosis (ALS) Amyotrophic lateral sclerosis (ALS), also called Lou Gehrig's disease, is a progressive neurological disease affecting 30,000 Americans with about 5,000 new cases occurring in the United States each year. ALS belongs to a class of disorders known as motor neuron diseases. Motor neurons are nerve cells located in the brain, brainstem, and spinal cord that serve as controlling units and vital communication links between the nervous system and the voluntary muscles of the body. The loss of these cells causes the muscles under their control to weaken and waste away, leading to paralysis. It is usually fatal within five years of diagnosis. ALS manifests itself in different ways, depending on which muscles weaken first. Symptoms may include tripping and falling, loss of control in hands and arms, difficulty speaking, swallowing and/or breathing, persistent fatigue, and twitching and cramping. ALS strikes in mid-life. Men are about one-and-a-half times more likely to have the disease as women. Because ALS affects only motor neurons, the disease does not impair a person's mind, personality, intelligence, or memory. It does not affect a person's ability to see, smell, taste, hear, or recognize touch. Patients usually maintain control of eye muscles and bladder and bowel functions. There is no cure for ALS, nor is there a proven therapy that will prevent or reverse its course.
  • Annual Report 2010 Letter from the CEO

    Annual Report 2010 Letter from the CEO

    ANNUAL REPORT 2010 Letter from the CEO Last year, my family, like many other families across the world, was impacted by a potentially life threatening medical condition. Due to amazing and rapid advances in cardiovascular research and drug development, the crisis has passed and the condition can be treated chronically. We were obviously blessed to have access to these existing life saving medications. These medications continue to reduce the risk of further incidence of cardiovascular events allowing my family to return to a normal semblance of everyday life. This is the situation we need in ALS. We need to get to a point where there is an opportunity to recover and to live. That is what I am committed to doing and what all of us at ALS TDI believe is possible. This past year began with our team publishing a paper in Nature Genetics, describing a previously unknown biological process related to disease onset and progression. In that work, we identified a monoclonal antibody which effectively altered that process in such a way that the disease slowed down in the preclinical model in ways we had not previously seen. Always with an eye on clinical translation, we looked toward our human gene expression database to confirm whether or not that pathway was, in fact, present similarly in people living with the disease. The data was undeniable, with nearly 60% of samples from PALS showing a clear up-regulation of the co-stimulatory pathway; leading us to believe that for the first time, we had found sufficient evidence to move a potential therapeutic into the clinic.